GCM
LLY icon

Glaxis Capital Management’s Eli Lilly LLY Stock Holding History

Glaxis Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.61M Buy
+4,680
New +$4.78M 11.28% 2
2024
Q4 		– Sell
-500
Closed -$443K – 44
2024
Q3 		$443K Buy
+500
New +$450K 1.72% 18
2024
Q1 		– Sell
-1,000
Closed -$583K – 68
2023
Q4 		$583K Buy
+1,000
New +$584K 2.03% 20

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Glaxis Capital Management's LLY Position: Q2 2026 in Review

Glaxis Capital Management opened a new position in Eli Lilly (LLY) in Q2 2026: 4,680 shares worth $5.61M. The stake represents 11.28% of the portfolio and ranks #2 among its holdings. This is a return to the name: Glaxis Capital Management previously reported a position in LLY as recently as Q3 2024.

Glaxis Capital Management first reported a position in LLY in Q4 2023 and has held it in 3 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Glaxis Capital Management held 4,680 shares of Eli Lilly worth $5.61M as of Q2 2026.
  • Eli Lilly was a new Glaxis Capital Management position in Q2 2026.
  • Eli Lilly made up 11.28% of Glaxis Capital Management's portfolio in Q2 2026, its #2 holding.
  • Glaxis Capital Management first reported a position in Eli Lilly in Q4 2023 and has held it in 3 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Glaxis Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.